Physician

John C Puente, M.D.

According to 2025 Medicare claims, John Puente, M.D. (NPI: 1194775916) practices neurology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is BE WELL MD PLLC (NPI: 1780128140; TIN: 465219431) and primary practice location at 68516-5536. Puente is affiliated with the CommonSpirit ACO I (ACO ID: A2164), NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Puente's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 522 traditional Medicare patients, billed 12,447 HCPCS/CPT codes, and received $115,172 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 4,533 prescription claims across 774 beneficiaries totaling $1,961,713 in drug costs, led by Kesimpta Pen (Ofatumumab). DME data shows 25 claims. Open Payments data shows 168 records totaling $103,449. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,180 to $4,094.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	472	7,856	$167,426
2016	482	2,496	$77,921
2017	528	4,693	$89,701
2018	516	11,668	$127,194
2019	438	10,859	$111,646
2020	373	13,778	$119,208
2021	368	14,597	$124,706
2022	328	11,019	$104,351
2023	367	9,778	$106,507
2024	522	12,447	$115,172

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	299	3,355	$2,603,913
2016	331	3,602	$2,866,190
2017	332	3,326	$3,005,140
2018	372	3,630	$2,703,599
2019	398	3,879	$2,961,894
2020	375	3,592	$2,963,077
2021	353	3,376	$2,216,285
2022	382	3,651	$2,636,532
2023	416	3,824	$2,672,544
2024	774	4,533	$1,961,713

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$3,934
2019	N/R	11	$213
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	30	$1,384
2024	N/R	25	$575

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	206	206	$155
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	184	202	$127
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	196	196	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	69	78	$92

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kesimpta Pen	Ofatumumab	26	736	$240,837
Nuplazid	Pimavanserin Tartrate	44	973	$163,611
Ingrezza	Valbenazine Tosylate	19	570	$162,616
Aimovig Autoinjector	Erenumab-Aooe	137	4,196	$108,274
Fycompa	Perampanel	50	1,567	$62,424

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	25	$575

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	155	$8,792	Celgene Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	13	$94,657	Sage Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John C. Puente, M.D.?

Tedicare shows public-source Medicare data for John C. Puente, M.D. (NPI 1194775916), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John C. Puente, M.D. have ACO affiliation data?

John C. Puente, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to John C. Puente, M.D.?

John C. Puente, M.D. is linked to BE WELL MD PLLC (billing NPI 1780128140) in the available physician profile data.

Does John C. Puente, M.D. have Open Payments data?

John C. Puente, M.D. has 168 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.